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Replacement of the ascending aorta in children: A series of
fourteen patients
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Aortic root dilatation is mainly observed in childrenwith various connective tissue disorders. The mostfrequent cause of aortic root dilatation is infantileMarfan syndrome.1 Aortic root dilatation has also
been recognized as being associated with bicuspid aortic valves,
with or without coarctation.2 The isolated forms are rare.3 This
dilatation may be worrisome, because it can lead to aortic insuf-
ficiency or dissection. Here we report a series of 14 children who
underwent ascending aorta replacement.
Patients, Methods, and Results
Fourteen children and adolescents (median 6 years, range 1-16.5
years; Table 1) underwent reconstruction of the ascending aorta
with mechanical replacement of the aortic valve in 5 cases (Bentall
procedure) and with preservation of native aortic valve in 9 cases
(Yacoub procedure; Table 2). Three had undergone previous op-
erations. Indication for the elective ascending aorta replacement
was either major dilatation of the aorta or rapid progression of the
aortic diameter. The mean ascending aortic diameter at surgery
was 46.5 mm (27-63 mm), and the median rate of progression of
the aortic root diameter was 7.5 mm during the year preceding the
aortic replacement (range 2-26 mm). The Bentall procedure was
chosen in advance in 4 of 5 cases because significant aortic
insufficiency was already present. In the last of the 5 cases (patient
8), the decision to replace the aortic valve was taken during the
procedure because the valve appeared too altered to be preserved.
One patient with infantile Marfan syndrome (patient 2) died 2 days
after the operation of massive mitral regurgitation after an at-
tempted mitral valve replacement. Four patients underwent addi-
tional concomitant procedures. Four patients required reoperation.
Thirteen patients were alive at last follow-up (mean 4.7  1.2
years, range 1.5-6.5 years) without symptoms.
Discussion
Surgery in children with dilatation of the ascending aorta or aortic
root can be a challenge. Aortic replacement should be recom-
mended to prevent rupture or dissection. In addition, aortic root
replacement with aortic valve sparing is attractive for children who
have a normally functioning aortic valve because it may avoid
From the Service de Cardiologie Pe´diatrique et de Chirurgie Cardiaque
Pe´diatrique, Hoˆpital Necker-Enfants Malades, Paris, France.
Received for publication Jan 24, 2002; accepted for publication Feb 10,
2002.
Address for reprints: Damien Bonnet, MD, Service de Cardiologie Pe´di-
atrique, Hoˆpital Necker-Enfants Malades, 149, rue de Se`vres 75743 Paris
Cedex 15, France (E-mail: damien.bonnet@nck.ap-hop-paris.fr).
J Thorac Cardiovasc Surg 2002;124:411-3
Copyright © 2002 by The American Association for Thoracic Surgery
0022-5223/2002 $35.000 12/54/123706
doi:10.1067/mtc.2002.123706
TABLE 1. Patient characteristics
Case Associated syndrome or lesions
Age at
operation
(y)
Aortic diameter
at operation
(mm)
Rate of
progression*
(mm) Previous procedures
Aortic
insufficiency†
1 Marfan syndrome 1 30 13 None 1
2 Marfan syndrome 1.5 52 26 None 3
3 Aortic valve dysplasia 2 50 6 None 3
4 Marfan syndrome 4 42 10 None 1
5 Marfan syndrome 4 51 5 None 1
6 Megadolichoaorta 5 43 4.6 None 1
7 Bicuspid aortic valve 6 27 9.5 Ross 3
8 Marfan syndrome 7 62 10 None 1
9 Coarctation of aorta and bicuspid
aortic valve
10 50 9 None 1
10 Turner syndrome 12 41 4 None 0
11 Ehlers-Danlos syndrome type III 12 47 8.5 Pulmonary artery aneurysm 1
12 Coarctation of aorta 16 40 4 Coarctation repair 3
13 Bicuspid aortic valve 16.5 63 4.5 None 2
14 Marfan syndrome 16.5 53 6 None 2
*Rate of progression is the increase in diameter during the year that preceded the aortic replacement.
†Scale ranges from 0 (none) to 3 (extreme).
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anticoagulation. The timing of surgery therefore has to take into
account the aortic diameter, the rate of progression of the dilata-
tion, the function of the aortic valve, and the potential deterioration
of valve function according to the known natural history of a given
connective tissue defect. Even all this information may not be
sufficient, because the risk of reoperation has also to be consid-
ered. In our series, 2 patients with Marfan syndrome (patients 5
and 14) had to undergo aortic valve replacement for aortic insuf-
ficiency 3 years after a Yacoub procedure. Patient 1, who had
severe neonatal Marfan syndrome, already had important mitral
and tricuspid valves prolapses at the time of the Yacoub procedure,
but there was no regurgitation. A few months later, this patient had
to be reoperated on for symptomatic mitral valve regurgitation.
Patient 2 was similar and died after the operation of massive mitral
regurgitation. Because of these cases, the third patient with neo-
natal Marfan syndrome and mitral valve prolapse (patient 4) un-
derwent both procedures simultaneously while there was a trivial
mitral regurgitation. Finally, the patient with megadolichoaorta
(patient 6) had an aneurysm develop in the horizontal aorta above
the conduit placed during the Yacoub procedure. He had moderate,
asymptomatic aortic regurgitation, but we decided to replace the
aortic valve during the reoperation to avoid a third procedure.
With respect to the aortic diameter, we followed the recom-
mendations established for Marfan syndrome.4 We subjected pa-
tients to prophylactic surgery when the aortic diameter was larger
than 50 mm or when the progression of the dilatation was rapid,
regardless of age. The patient with Turner syndrome (patient 10)
had a moderate dilatation of the aorta with a rate of progression of
4 mm/y, but she was hypertensive and wanted to receive estrogens
and progesterone to initiate puberty. Because of the high risk of
dissection in this condition,5 she was operated on even though the
absolute value of her aortic diameter was relatively low relative to
standard recommendations for prophylactic interventions.
It is difficult to draw conclusions from short series. In our
experience, replacement of the ascending aorta in children has a
low operative risk but a high reoperation rate. Reoperation could
TABLE 2. Ascending aorta replacement, additional procedures, and follow-up
Case Procedure Additional procedures Subsequent procedures
Follow-up
(y)
Aortic
insufficiency*
1 Yacoub None Mitral and tricuspid valve
replacements (2 y)
4 1
2 Bentall
(CarboMedics†
16 mm)
None Mitral valve replacement (2 d
after Yacoub procedure)
Died 0
3 Bentall
(Duromedics‡
16 mm)
None None 5 0
4 Yacoub Mitral and tricuspid valve
replacements
None 1.5 1
5 Yacoub None Bentall (St Jude Medical§ 25
mm) and aortic arch
replacement (8 y)
2 0
6 Yacoub None Bentall (St Jude Medical§ 25
mm) and aortic arch
replacement (6.5 y)
1.5 0
7 Bentall
(CarboMedics†
21 mm)
None None 5.5 0
8 Bentall (St Jude
Medical§ 25
mm)
None None 6.5 0
9 Yacoub Coarctation repair None 6 0
10 Yacoub None None 3 1
11 Yacoub None None 2.5 1
12 Bentall
(CarboMedics†
25 mm)
None None 4 0
13 Yacoub Aortic valve
commissurotomy
None 3.5 2
14 Yacoub None Bentall (St Jude Medical§ 25
mm, 19 y)
6 0
*Scale ranges from 0 (none) to 3 (extreme).
†CarboMedics, Inc, Austin, Tex.
‡Hemex Scientific Inc, Austin, Tex.
§St Jude Medical Inc, Minneapolis, Minn.
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be avoided in cases of neonatal Marfan syndrome by repairing
significant mitral valve prolapse during the same procedure. Wors-
ening of aortic regurgitation occurs in Marfan syndrome after the
Yacoub procedure, which raises the question of prophylactic aortic
valve replacement as a primary procedure in this condition.
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